Connect with us

Published

on

Amazon launches RxPass; new prescription perk for U.S. Prime members

Amazon on Tuesday announced a new prescription perk for U.S. Prime members, hoping to boost subscriptions and attract users to its pharmacy service.

The add-on, called RxPass, will allow Prime members to get as many drugs as they need from a list of 50 generic medications to treat more than 80 common chronic conditions, such as high blood pressure, anxiety and diabetes. The service costs $5 a month per person, and delivery is free.

Amazon has pushed deeper into health care in recent years. The company launched its own online pharmacy in 2020, a service that was born out of its acquisition of PillPack in 2018. Amazon introduced, then shuttered, a telehealth service called Amazon Care, and announced in July it would acquire boutique primary care provider One Medical.

Amazon also offers a Prime prescription savings benefit, which offers a discount of up to 80% on generic medications and up to 40% on brand-name prescriptions.

Amazon is beefing up perks for its Prime subscription program as CEO Andy Jassy looks to cut costs elsewhere in the company. Amazon has eyed laying off about 18,000 employees, while it froze hiring in its corporate workforce and axed some projects. Still, Jassy has said Amazon intends to keep pursuing long-term opportunities, including health care.

The e-retailer faces competition in pharmacy from the likes of CVS, Walgreens and Walmart. Amazon hasn’t said how its online pharmacy offering has fared since its launch. An August report from Morgan Stanley found Amazon Pharmacy didn’t rank as a top perk for Prime members, based on a survey of users, according to Business Insider.

Amazon’s chief medical officer, Vin Gupta, said the company is aiming to deliver a pharmacy experience that is “fundamentally different” from how pharmacies have existed over the last several decades.

“This is still day one for us where we’re at our beginning stages here, but we recognize that change is needed,” Gupta said in an interview. “That’s what patients across the country are telling us, and that’s what Amazon is responding to.”

RxPass doesn’t offer insulin or specialty medications, and it’s not available for people on Medicaid or Medicare. Gupta declined to say whether Amazon will expand the list of medications offered through RxPass in the future.

Approximately 150 million people are on at least one of the medications included in the initial RxPass formulary, he said.

— CNBC’s Bertha Coombs contributed to this article.

Continue Reading

Technology

Tesla shares dip in premarket trade after reports the firm will lay off more than 10% of global workforce

Published

on

By

Tesla shares dip in premarket trade after reports the firm will lay off more than 10% of global workforce

A Tesla supercharger is shown at a charging station in Santa Clarita, California, U.S. October 2, 2019. 

Mike Blake | Reuters

Tesla shares were down over 1% in premarket trade Monday on media reports that the automaker will lay off more than 10% of its global workforce.

The company’s stock was down 1.2% in premarket deals at roughly 7:30 a.m. ET.

“As we prepare the company for our next phase of growth, it is extremely important to look at every aspect of the company for cost reductions and increasing productivity,” Tesla CEO Elon Musk said in an internal memo cited by Reuters, which tech publication Electrek referenced in the first report of the layoffs.

“As part of this effort, we have done a thorough review of the organization and made the difficult decision to reduce our headcount by more than 10% globally,” the memo said.

CNBC was unable to independently verify the memo and has reached out for comment.

Tesla had 140,473 employees as of December 2023.

Tesla is going through a 'code red situation' right now, says Wedbush's Dan Ives

Tesla shares have taken a bruising in recent months, down 31% in the year-to-date amid waning demand for electric vehicles and stiffening competition from Chinese automakers. Foreshadowing layoffs, the company earlier this month reported its first annual decline in vehicle deliveries since 2020, when the Covid-19 pandemic disrupted production extraneous of demand — first-quarter deliveries fell by 8.5% on the year to 386,810 in the first quarter, with output down 1.7% from a year earlier and 12.5% sequentially.

Deliveries serve as an approximation of Tesla sales but are not precisely defined in the company’s shareholder communications.

Since then, the firm has also resorted to trimming the subscription price of its premium driver assistance system, the Full Self-Driving package, for U.S. customers — in a move sharply at odds with Musk’s previous pledges that the FSD fee would only bulk up as Tesla bolsters the system’s features and functionality.

This breaking news story is being updated.

Continue Reading

Technology

Freetrade, Britain’s answer to Robinhood, posted its first quarterly profit

Published

on

By

Freetrade, Britain's answer to Robinhood, posted its first quarterly profit

The Freetrade logo on a smartphone screen.

Rafael Henrique | Sopa Images | Lightrocket | Getty Images

British stock trading app Freetrade hit eked out breakeven earlier this year, the company told CNBC, marking its first-ever move into the black after incurring full-year losses in 2023.

Freetrade reported adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) of £100,000 ($124,863) in the first quarter of 2024, according to unaudited financial statements shared with CNBC.

Preliminary revenue hit £6.7 million in the quarter.

Freetrade still generated a loss of £8.3 million in 2023, down from the £28.8 million loss it racked up the year before. Revenues climbed to £21.6 million last year, up 45% from 2022.

“We defied difficult market conditions and delivered healthy growth in 2023 while dramatically reducing losses” in 2022, said Adam Dodds, CEO and founder of Freetrade.

Equity crowdfunders rejoice

The development will be welcome news for Freetrade’s crowdfunding investors, who’ve been looking for an update on the company’s move toward profitability after a tough financial period.

Freetrade saw its valuation reduced by 65% to £225 million ($280.3 million) from £650 million in 2023 in its latest equity crowdfunding round on Crowdcube, with the company blaming a “different market environment” plagued by higher interest rates and inflation.

Net inflows totalled £130 million in the first quarter, too, as retail investor activity grew in response to resurgent markets last year. Assets under administration also reached £1.8 billion.

“Importantly for our crowdfunding investors, we laid out a clear path towards breakeven during our last fundraise,” Dodds said.

“As we look ahead to the rest of 2024, we’ve got major product developments that are going to support our next phase of growth with preparations being made to roll out our web platform.”

Equity markets saw serious drops in 2022 as a result of macroeconomic uncertainty and higher interest rates stoked by Russia’s full-fledged invasion of Ukraine, which triggered a risk-off trade around the world.

Britain’s answer to Robinhood

Continue Reading

Technology

OpenAI opens its first Asia office in Japan as a ‘first step’ in its commitment to the region

Published

on

By

OpenAI opens its first Asia office in Japan as a 'first step' in its commitment to the region

In this photo illustration, an OpenAI logo is displayed on a smartphone screen. 

Rafael Henrique | SOPA Images | Lightrocket | Getty Images

OpenAI has opened its first Asian office in Tokyo, Japan as the ChatGPT developer aims to expand its global presence.

“We’re excited to be in Japan which has a rich history of people and technology coming together to do more,” CEO Sam Altman said in the statement released Sunday. “We believe AI will accelerate work by empowering people to be more creative and productive, while also delivering broad value to current and new industries that have yet to be imagined.”

As part of the move, the company has appointed Tadao Nagasaki as the new president of OpenAI Japan, to head commercial and market engagement efforts.

Tokyo was chosen due to “its global leadership in technology, culture of service, and a community that embraces innovation.”

“As a first step in our long-term commitment to the region, we’re providing local businesses with early access to a GPT-4 custom model specifically optimized for the Japanese language,” according to the statement.

“This custom model offers improved performance in translating and summarizing Japanese text, is cost effective, and operates up to 3x faster than its predecessor,” it added.

Japanese corporations like Daikin, Toyota as well as local governments are using ChatGPT to improve their efficiency, the company said.

Altman met with Prime Minister Fumio Kishida last year and reportedly mentioned he was looking into opening a new office in Japan.

The artificial intelligence startup burst into the mainstream after the public launch of the ChatGPT chatbot in late 2022. The company is backed by Microsoft and has a private market valuation that’s reportedly approaching $100 billion.  

Last week, Microsoft said it will be investing $2.9 billion over the next two years to increase its hyperscale cloud computing and AI infrastructure in Japan.

This is the “single largest investment in its 46-year history in Japan, also the site of its first international office,” Microsoft said.

Continue Reading

Trending